Marker Therapeutics Inc (MRKR)
3.70
+0.18
(+5.11%)
USD |
NASDAQ |
Nov 05, 16:00
3.70
0.00 (0.00%)
After-Hours: 16:04
Marker Therapeutics Total Liabilities (Quarterly): 1.972M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.972M |
| March 31, 2024 | 2.304M |
| December 31, 2023 | 3.075M |
| September 30, 2023 | 2.780M |
| June 30, 2023 | 2.921M |
| March 31, 2023 | 12.03M |
| December 31, 2022 | 14.82M |
| September 30, 2022 | 18.51M |
| June 30, 2022 | 24.29M |
| March 31, 2022 | 19.25M |
| December 31, 2021 | 24.15M |
| September 30, 2021 | 19.66M |
| June 30, 2021 | 17.23M |
| March 31, 2021 | 15.87M |
| December 31, 2020 | 18.27M |
| September 30, 2020 | 17.97M |
| June 30, 2020 | 14.01M |
| March 31, 2020 | 3.390M |
| December 31, 2019 | 2.273M |
| September 30, 2019 | 3.521M |
| June 30, 2019 | 3.591M |
| March 31, 2019 | 3.377M |
| December 31, 2018 | 2.804M |
| September 30, 2018 | 3.701M |
| June 30, 2018 | 3.747M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.314M |
| December 31, 2017 | 1.522M |
| September 30, 2017 | 1.768M |
| June 30, 2017 | 1.576M |
| March 31, 2017 | 1.964M |
| December 31, 2016 | 1.737M |
| September 30, 2016 | 2.204M |
| June 30, 2016 | 23.12M |
| March 31, 2016 | 31.46M |
| December 31, 2015 | 28.01M |
| September 30, 2015 | 8.847M |
| June 30, 2015 | 13.06M |
| March 31, 2015 | 3.302M |
| December 31, 2014 | 1.248M |
| September 30, 2014 | 1.300M |
| June 30, 2014 | 2.598M |
| March 31, 2014 | 5.615M |
| December 31, 2013 | 8.845M |
| September 30, 2013 | 5.253M |
| June 30, 2013 | 4.956M |
| March 31, 2013 | 5.652M |
| December 31, 2012 | 6.130M |
| September 30, 2012 | 4.428M |
| June 30, 2012 | 3.881M |
| March 31, 2012 | 3.700M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.972M
Minimum
Jun 2024
24.29M
Maximum
Jun 2022
12.36M
Average
14.82M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.613M |
| Perspective Therapeutics Inc | 44.92M |
| Protalix BioTherapeutics Inc | 62.96M |
| Electromed Inc | 7.689M |
| Armata Pharmaceuticals Inc | 154.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.68M |
| Shareholders Equity (Quarterly) | 9.703M |